Diagnostics of medullary thyroid cancer and the strategy of its management in the absence of biochemical remission

Early diagnosis greatly facilitates successful treatment of medullary thyroid cancer. The present paper is designed to report the results of analysis of the studies carried out with the use of various diagnostic techniques and the data obtained during the long-term treatment of the patients with this pathology in the absence of biochemical remission.

• Publication year

  2011

• Venue

  Unknown venue

• Publication date

  2011-12-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.14341/PROBL201157645-51
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Medullary thyroid carcinoma.

  2013cited by this paper
• Medullary Thyroid Cancer: Management Guidelines

  2012cited by this paper
• The use of preoperative routine measurement of basal serum thyrocalcitonin in candidates for thyroidectomy due to nodular thyroid disorders: results from 2733 consecutive patients.

  2011cited by this paper
• Ultrasonographic features of medullary thyroid carcinoma and their diagnostic values.

  2010cited by this paper
• Medullary thyroid carcinoma: comparison with papillary thyroid carcinoma and application of current sonographic criteria.

  2010cited by this paper
• Ultrasonographic Findings of Medullary Thyroid Carcinoma: a Comparison with Papillary Thyroid Carcinoma

  2009cited by this paper
• Potency and tolerance of calcitonin stimulation with high-dose calcium versus pentagastrin in normal adults.

  2009cited by this paper
• Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer.

  2009cited by this paper
• Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomas

  2009cited by this paper
• Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times.

  2008cited by this paper
• Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.

  2008cited by this paper
• Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost-effectiveness and decision analysis.

  2008cited by this paper
• Long-term Outcome of Reoperations for Medullary Thyroid Carcinoma

  2008cited by this paper
• Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules.

  2007cited by this paper
• Reference range of serum calcitonin levels in humans: influence of calcitonin assays, sex, age, and cigarette smoking.

  2007cited by this paper
• Calcitonin measurement in wash-out fluid from fine needle aspiration of neck masses in patients with primary and metastatic medullary thyroid carcinoma.

  2007cited by this paper
• Surgical approach to medullary thyroid cancer.

  2007cited by this paper
• Survival improvement in patients with medullary thyroid carcinoma who undergo pretargeted anti-carcinoembryonic-antigen radioimmunotherapy: a collaborative study with the French Endocrine Tumor Group.

  2006cited by this paper
• Preoperative diagnosis of medullary thyroid carcinoma: Fine needle aspiration cytology as compared with serum calcitonin measurement

  2005cited by this paper
• Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma.

  2005cited by this paper
• Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.

  2004cited by this paper
• Surgical treatment of medullary thyroid carcinoma *

  2003cited by this paper
• Lymph node dissection and medullary thyroid carcinoma

  2002cited by this paper
• Prognostic value of codon 918 (ATG→ACG) RET proto‐oncogene mutations in sporadic medullary thyroid carcinoma

  2001cited by this paper
• Routine Measurement of Serum Calcitonin is Useful for Early Detection of Medullary Thyroid Carcinoma in Patients with Nodular Thyroid Diseases

  2001cited by this paper
• Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma

  2001cited by this paper
• Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer.

  2000cited by this paper
• Medullary Thyroid Carcinoma

  2000cited by this paper
• Medullary thyroid cancer: multivariate analysis of prognostic factors influencing survival.

  2000cited by this paper
• Normal Preoperative Calcitonin Levels Do Not Always Exclude Medullary Thyroid Carcinoma in Patients with Large Palpable Thyroid Masses

  2000cited by this paper
• Medullary thyroid carcinoma

  2000cited by this paper
• Cytologic diagnosis of medullary carcinoma of the thyroid gland

  2000cited by this paper
• Somatic Mutations in RET Exons 12 and 15 in Sporadic Medullary Thyroid Carcinomas: Different Spectrum of Mutations in Sporadic Type from Hereditary Type

  1999cited by this paper
• Basal Calcitonin Levels and the Response to Pentagastrin Stimulation in Patients After Kidney Transplantation or on Chronic Hemodialysis as Indicators of Medullary Carcinoma

  1999cited by this paper
• Novel Point Mutations and Allele Loss at the RET Locus in Sporadic Medullary Thyroid Carcinomas

  1998cited by this paper
• Somatic Mutations in the RET Protooncogene in Japanese and Chinese Sporadic Medullary Thyroid Carcinomas

  1998cited by this paper
• A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985‐1995

  1998cited by this paper
• A rapid method for DNA extraction from fine-needle aspiration biopsies of thyroid tumors, and subsequent RET mutation analysis.

  1998cited by this paper
• Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients

  1998cited by this paper
• 5‐fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors

  1998cited by this paper
• Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group.

  1997cited by this paper
• C cell hyperplasia/neoplasia.

  1997cited by this paper
• Progression of postoperative residual medullary thyroid carcinoma as monitored by plasma calcitonin levels.

  1996cited by this paper
• Somatic mutations in the RET proto‐oncogene in sporadic medullary thyroid carcinoma

  1996cited by this paper
• Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine

  1994cited by this paper
• Determination of silica-purified plasma calcitonin for the detection and management of medullary thyroid carcinoma: comparison of two provocative tests.

  1987cited by this paper
• Relation of Doubling Time of Plasma Calcitonin Levels to Prognosis and Recurrence of Medullary Thyroid Carcinoma

  1984cited by this paper
• Medullary thyroid carcinoma. Importance of serial serum calcitonin measurement

  1979cited by this paper
• Medullary Thyroid Carcinoma: Relationship of Method of Diagnosis to Pathologic Staging

  1978cited by this paper
• Provocative Agents and the Diagnosis of Medullary Carcinoma of the Thyroid Gland

  1978cited by this paper

• No citing papers are available for this paper.